Thomas Steyer’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History

Thomas Steyer’s Portfolio ZEAL Stock Details ZEAL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-496,890	Closed	-$7.75M	–	330
2022 Q1	$7.75M	Sell	496,890 -13,110	-3%	-$221K	0.04%	156
2021 Q4	$10.9M	Hold	510,000	–	–	0.05%	127
2021 Q3	$14.3M	Hold	510,000	–	–	0.07%	121
2021 Q2	$15.1M	Hold	510,000	–	–	0.06%	112
2021 Q1	$16.3M	Hold	510,000	–	–	0.08%	111
2020 Q4	$18.3M	Buy	510,000 +5,000	+1%	+$188K	0.11%	90
2020 Q3	$19.2M	Buy	505,000 +5,000	+1%	+$181K	0.13%	86
2020 Q2	$17.5M	Sell	500,000 -250,000	-33%	-$8.89M	0.14%	93
2020 Q1	$25.9M	Sell	750,000 -259,800	-26%	-$9.05M	0.22%	61
2019 Q4	$33.5M	Sell	1,009,800 -200	-0%	-$5.98K	0.23%	68
2019 Q3	$25.6M	Buy	1,010,000 +10,000	+1%	+$226K	0.19%	62
2019 Q2	$21.6M	Buy	1,000,000 +51,300	+5%	+$1.04M	0.14%	75
2019 Q1	$16.1M	Buy	948,700 +48,700	+5%	+$730K	0.12%	77
2018 Q4	$10.4M	Hold	900,000	–	–	0.08%	81
2018 Q3	$14.9M	Hold	900,000	–	–	0.09%	76
2018 Q2	$11.4M	Buy	900,000 +35,000	+4%	+$532K	0.07%	75
2018 Q1	$13M	Buy	865,000 +215,000	+33%	+$3.34M	0.09%	69
2017 Q4	$8.84M	Hold	650,000	–	–	0.07%	69
2017 Q3	$12.5M	Buy	+650,000	New	+$12.2M	0.11%	67

Other funds holding ZEAL

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Thomas Steyer's ZEAL Position: Q2 2022 in Review

Thomas Steyer sold out of Zealand Pharma A/S American Depositary Shares (ZEAL) in Q2 2022, closing a stake of 496,890 shares — an estimated $7.75M sold.

Thomas Steyer first reported a position in ZEAL in Q3 2017 and held it in 19 quarters. The position peaked at $33.5M in Q4 2019. 11 funds tracked by Wall St. Rank hold ZEAL as of Q2 2022.

Thomas Steyer reported no remaining Zealand Pharma A/S American Depositary Shares position as of Q2 2022 after selling out during the quarter.
Thomas Steyer sold 496,890 Zealand Pharma A/S American Depositary Shares shares in Q2 2022, an estimated $7.75M.
Thomas Steyer first reported a position in Zealand Pharma A/S American Depositary Shares in Q3 2017 and held it in 19 quarters.
Thomas Steyer's Zealand Pharma A/S American Depositary Shares position peaked at $33.5M in Q4 2019.
11 funds tracked by Wall St. Rank held Zealand Pharma A/S American Depositary Shares as of Q2 2022.

Based on Farallon Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.